Adaptive Research and WRO to expand cancer trial access in San Francisco Bay Area
Adaptive Research and Western Radiation Oncology (WRO) have partnered to expand access to cancer treatment studies for individuals in the …
Post
-
-
Teva reports positive outcomes from episodic migraine trial in young patients
Teva Pharmaceutical Industries has reported positive outcomes from its multicentre Phase III SPACE trial of Ajovy (fremanezumab) as a preventive …
-
CEO of UnitedHealthcare, Brian Thompson, shot dead in New York City
The CEO of US healthcare insurance firm UnitedHealthcare Group has been shot dead by a masked gunman outside of the …
-
Lilly’s Zepbound wins the weight loss duel with Novo’s Wegovy
Eli Lilly has scored a win in the ongoing competition with Novo Nordisk in the obesity space, as a Phase …
-
Real world data and patient planning can keep trials from collapsing
The judicious use of real-world data (RWD) could keep a Phase I or II trial from collapsing with the market …
-
Study shows mortality impact of alcohol consumption in Mexico
Mexico's alcohol consumption patterns and their population-level health effects have received little scholarly attention, despite alcohol consumption’s status as a …
-
Vaxcyte doses first subject in pneumococcal conjugate vaccine trial in infants
Vaxcyte has commenced the Phase II trial of its 31-valent pneumococcal conjugate vaccine (PCV) candidate, VAX-31, in healthy infants, with …
-
Patient data understanding must be a priority in trials, say expert panel
Trial sites and sponsors have been urged to consider the burden of arbitrary data collection on patients participating in trials …
-
“Preparation key” to prevent airfreight transit delay of medicines to clinical trials
Airline passenger numbers may have been slow to rise after the Covid-19 pandemic, but air cargo’s rebound was much quicker. …
-
Cartesian shares updated Phase IIb Descartes-08 data and announces Phase III trial plans
Cartesian Therapeutics has announced updated efficacy and safety data from the Phase IIb trial of its mRNA cell therapy candidate …
-
VivaVision to advance non-steroidal therapy in Phase III following Phase II win
China-headquartered VivaVision Biotech is looking to advance its non-steroidal therapy, VVN461-CS-201 (VVN461), in a Phase III trial after the candidate …
-
Arrowhead seeks approval to begin RNAi therapy trial for obesity treatment
Arrowhead Pharmaceuticals has submitted an application to the New Zealand Medicines and Medical Devices Safety Authority seeking clearance to commence …
-
Medical firms urged not to let assumptions put patients at risk
Assumptions, poor record keeping, or a lack of viable information can stand in the way of trial progress and push …
-
Gate Neurosciences and Pitt commence antidepressant drug trial
Gate Neurosciences and the University of Pittsburgh (Pitt) have commenced a Phase II clinical trial to evaluate the potential of …
-
Parents urged to vaccinate children in wake of UK pneumonia epidemic
Pneumonia epidemic peaks historically occur every four to seven years, with the last epidemic of pneumonia in the UK occurring …
